The company’s performance missed analyst targets across every major metric. While the market had anticipated a pivot toward profitability, AdaptHealth reported a GAAP loss of $0.99 per share, far exceeding the projected $0.15 loss. Adjusted EBITDA also stalled at $132 million, missing the expected $160 million mark.

Following the earnings release, the law firm Levi & Korsinsky launched an investigation on behalf of shareholders who suffered financial losses. Attorneys are currently reviewing whether the company issued misleading statements regarding its financial health or future performance. Affected investors are encouraged to contact Joseph E. Levi at (212) 363-7500 or via email to evaluate potential claims. Participation in the investigation does not require out-of-pocket costs or court appearances, as cases are typically handled on a contingency basis.